Literatur
Peerdeman KJ et al. Expectations about the effectiveness of pain- and itch-relieving medication administered via different routes. Eur J Pain. 2018 Apr;22(4):774-83
Derry S et al. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;1(1):CD007393
Häuser W, Hansen E, Enck P. Nocebophänomene in der Medizin. Dtsch Arztebl Int. 2012;109(26):459-65
Freynhagen R, Argoff C, Eerdekens M, Engelen S, Perrot S. Progressive response to repeat application of capsaicin 179 mg (8 % w/w) cutaneous patch in peripheral neuropathic pain: Comprehensive new analysis and clinical implications. Pain Med. 2021;22(10):2324-36
Dibbelt S, Schaidhammer M, Fleischer C et al. Patient-Arzt-Interaktion in der Rehabilitation: Gibt es einen Zusammenhang zwischen wahrgenommener Interaktionsqualität und langfristigen Behandlungsergebnissen? Die Rehabilitation. 2010;49(05):315-25
Waber RL, Shiv B, Carmon Z, Ariely D. Commercial features of placebo and therapeutic efficacy. JAMA. 2008;299(9):1016-7
Richard H. Thaler Cass R. Sunstein NUDGE - Improving Decisions About Health, Wealth, and Happiness. New Haven, London: Yale University Press; 2008
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Papenhoff, M. Topische Therapie bei neuropathischen Schmerzen richtig kommunizieren. Schmerzmed. 39, 39–41 (2023). https://doi.org/10.1007/s00940-023-4262-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00940-023-4262-6